The president signed a law on the creation of a compensation fund

Vaccinated and hospitalized for adverse vaccinations will be able to apply for a compensation benefit without the need to refer to the lengthy court procedure – provided for in the act signed by President Andrzej Duda on Tuesday.

The amendment to the law on preventing and combating infections and infectious diseases provides for the creation of a compensation fund for people who are admitted to hospital due to adverse vaccine reactions (NOP).

Compensation benefit in the case of observation in a hospital emergency department or emergency room in connection with an anaphylactic shock is PLN 3,000. zloty. People who have been hospitalized for an anaphylactic shock for less than 14 days may receive £ 10,000. zloty. In the case of hospitalization (in six ranges) from 14 to more than 120 days, the benefit amounts to PLN 10,000. PLN up to 100 thousand. PLN – in proportion to the period of hospitalization.

The compensation benefit is additionally increased in the event of another event explicitly specified in the act, depending on its duration and type, by the amount from 5,000 PLN up to 20 thousand. zloty. The compensation benefit also covers the reimbursement of the costs of further treatment or rehabilitation after the completion of observation or hospitalization, in the amount not exceeding PLN 10,000. zloty. The total amount of the compensation benefit may not exceed PLN 100,000. PLN

The regulation applies to reactions that occurred after vaccination against COVID-19 from the beginning of their implementation, as well as after compulsory vaccinations adopted from January 1, 2023 r.

The amendment stipulates that submitting an application for a compensation benefit will be subject to a fee of PLN 200, payable to the Fund’s bank account (the fee will be refunded in the event of

The benefit will be obtained under the administrative procedure concluded with an administrative decision of the Patient’s Rights Ombudsman, after obtaining the opinion of the Fund’s Benefits Team as part of this procedure Compensatory Protective Vaccinations. The deadline for considering the application will be two months.

The decision issued by the Ombudsman will be subject to a complaint to the administrative court. Team members will be appointed for five years by the Patient’s Rights Ombudsman, and it will be composed of at least 6 specialists – doctors specializing in infectious diseases, paediatrics, allergology, neurology, surgery, cardiology and pulmonology, useful in the substantive assessment of applications.

Regardless of the benefit received under the Fund, the person who decides to file a claim for compensation or damages in connection with the occurrence of adverse effects after vaccination, will have the right to to assert one’s rights in court proceedings. (PAP)

Author: Olga Zakolska

ozk / joz /

Related: National SARS-CoV-2 vaccination program

• 

  Kraska: I asked for an opinion on the amendment to exempt people with high p levels from vaccination opposed

  Yesterday, during the work on the bill on covid verification, an amendment was introduced to exempt people who have high levels of antibodies from vaccination. I asked the national consultants for an opinion on this matter – said Deputy Minister of Health Waldemar Kraska in the Sejm on Wednesday.

• 

  Doctor: The number of infections in children will be enormous

  Delta variant turned out to be especially infectious to children. That is why I am afraid that Omikron may be even more dangerous for the youngest and lead to the total occupancy of beds – told PAP.PL Dr. Lidia Stopyra, head of the Department of Infectious Diseases and Paediatrics at the Specialist Hospital. Stefan Żeromski in Krakow.

• 

  EMA: Initial studies confirm efficacy of vaccines against the omicron variant

  Preliminary studies confirm efficacy of vaccines against COVID-19 against infection variant omicron and indicate that these preparations largely protect against severe disease and hospitalization – reported the European Medicines Agency (EMA).